Viewing data from:

METOCLOPRAMIDE HYDROCHLORIDE

ANDA

METOCLOPRAMIDE HYDROCHLORIDE | A070184 | TEVA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: REGLAN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.0446

per ea

Lowest NADAC/Unit

$0.0446

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093220301METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
00093220305METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
00093220310METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
51079088820METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
60687063101METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$33.31

Highest Price

$63.59

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00093-2203-05METOCLOPRAMIDE HCL 10MG TAB	$33.31	FSS	AvKare, LLC	06/14/2028
00093-2203-10METOCLOPRAMIDE HCL 10MG TAB	$63.59	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs5 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

COSMA SPAMETOCLOPRAMIDE HYDROCHLORIDE

DMF 45231982

LIAOYUAN SILVER EAGLE PHARMACEUTICAL CO LTDMETOCLOPRAMIDE HYDROCHLORIDE

DMF 289872014

EMCURE PHARMACEUTICALS LTDMETOCLOPRAMIDE HYDROCHLORIDE USP

DMF 329912018

DINAMITE DIPHARMA SPAInactiveMETOCLOPRAMIDE HYDROCHLORIDE BP'80

DMF 43811981

ORGAMOL SAInactiveMETOCLOPRAMIDE

DMF 58131985

BOEHRINGER INGELHEIM CHEMICALS INCInactiveMETOCLOPRAMIDE

DMF 60701985

MEDICHEM SAInactiveMETOCLOPRAMIDE HYDROCHLORIDE

DMF 62391986

BENZOCHEM LIFESCIENCES PVT LTDInactiveMETOCLOPRAMIDE HYDROCHLORIDE USP

DMF 212712008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 10MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 29, 1985

No patent or exclusivity listings for this strength.